Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The EMBO Journal|October 3, 2002
Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1Alexander Tinnikov, Kristina Nordström, Peter Thorén, et al.
Thyroid : Official Journal of the American Thyroid Association|May 5, 2017
Contrasting Phenotypes in Resistance to Thyroid Hormone Alpha Correlate with Divergent Properties of Thyroid Hormone Receptor α1 Mutant ProteinsCarla Moran, Maura Agostini, Anne McGowan, et al.
Thyroid : Official Journal of the American Thyroid Association|July 17, 2020
Hyperthyroxinemia and Hypercortisolemia due to Familial DysalbuminemiaCarla Moran, Christoph Seger, Kevin Taylor, et al.
The Journal of Clinical Investigation|February 9, 2016
Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesisErik Schoenmakers, Bradley Carlson, Maura Agostini, et al.
European Thyroid Journal|December 27, 2021
Clinical Consequences of Variable Results in the Measurement of Free Thyroid Hormones: Unusual Presentation of a Family with a Novel Variant in the THRB Gene Causing Resistance to Thyroid Hormone SyndromeIrene Campi, Maura Agostini, Federica Marelli, et al.
The Lancet. Diabetes & Endocrinology|June 28, 2014
Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)α1 and TRα2: clinical, biochemical, and genetic analyses of three related patientsCarla Moran, Maura Agostini, W Edward Visser, et al.
Endocrinology|December 6, 2003
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gammaMaura Agostini, Mark Gurnell, David B Savage, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2013
An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor αCarla Moran, Nadia Schoenmakers, Maura Agostini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 21, 2014
A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemiaNadia Schoenmakers, Carla Moran, Irene Campi, et al.
Diabetes|April 7, 2018
A Pharmacogenetic Approach to the Treatment of Patients With PPARG MutationsMaura Agostini, Erik Schoenmakers, Junaid Beig, et al.
Pageof 2